Trial Profile
A Phase 1, Randomized, Open-Label, Crossover Safety and Pharmacokinetic Study of 400 mg Albaconazole as a Tablet Formulation Versus a Capsule Formulation in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Albaconazole (Primary)
- Indications Chagas disease; Mycoses; Onychomycosis; Tinea pedis; Vulvovaginal candidiasis
- Focus Pharmacokinetics
- Sponsors Stiefel Laboratories
- 11 Jun 2014 New trial record